VerifiedPharmaceutical Manufacturing· Founded 2019

Plus Therapeutics, Inc

Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate REYOBIQ™ is being evaluated in the multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.

7-day free trial · no credit card

Houston, United States24(11 to 50)$1M to <$10M2019plustherapeutics.com LinkedIn

Verified contacts

24

available on Kipplo

LinkedIn employees

24

11 to 50 range

Open roles

—

no listings

Distinct roles

19

indexed titles

Tech stack

1

tools in use

Monthly traffic

586

organic / mo

Sign up free to see all 24 verified contacts at Plus Therapeutics, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

24 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 24 verified contacts

Top roles at Plus Therapeutics, Inc

19 distinct titles indexed · top 10 shown.

2()
2senior accountant
1& -
1accounts payable specialist
1assistant director quality assurance
1century therapeutics, inc
1controller
1corporate counsel
1drug development and production intern
1manager, drug development and production
+9more titles

Sign up to unlock all 24 contacts at Plus Therapeutics, Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 24 verified contacts at Plus Therapeutics, Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Plus Therapeutics, Inc | Kipplo Discover